Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma

Published: January 2014
No. of Pages: 141
    ReportsandReports

This report is available at 15% Discount till 31st Jan 2017. To avail discount please contact at +1-888-391-5441 / sales@reportsandreports.com.


2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations.  We find these regulations to be 'decisive' in spurring generic penetration significantly, with the main beneficiary being the Japanese government (or society) and not the generic companies.  The implications of new price-reversions are going to have many facets and will change conventional business models.  We expect many support services industries - CMOs, CROs and other allied services industries to benefit from these structural changes, while API importers will suffer.  We also expect consolidation and M&A activities to spur in Japan.

Innovation Takes the Driver's Seat:  While the new regulations will change the current business philosophy of doing business in patent expired space (>45% to total Japan market), the policy makers also discourage 'me too' innovations at the same time. The regulators however tend to support the 'first time in the world' level innovations by providing 'innovation premiums'.  Japanese innovators will now become more serious and selective in their R&D approach.  Previous year the Japanese innovators have focused on acquiring assets in - autoimmune, orphan diseases and oncology fields (Annexure 5).  We expect this trend to prevail in the coming years.  We find some of the candidates to remain in the limelight in 2014 along with some new additions - Edoxaban (Daiichi Sankyo), Invokana (Mitsubishi Tanabe), Dolutegravir (Shionogi), BBI-608 (Dainippon Sumitomo), Vedolizumab (Takeda), Xtandi (Astellas), Nivolumab (Ono) to hand-pick a few of them. The reports explain detail analysis on these key candidates.

The 138 pages report contains the detailed discussion of Japan biopharmaceutical market – which includes- Our view on the impact of 2014 price cuts on generic companies and innovator companies and detailed discussion on key attributes (consolidation activities, potential of R & D pipeline candidates, generic threat in domestic Japan market etc…) of leading Japanese innovator companies- Astellas, Chugai, Daiichi Sankyo, Dainippon Sumitomo,  Eisai, Kyorin, Kyowa hakko Kirin, Mitsubishi Tanabe, Shionogi,  Takeda and  leading Japanese generic companies- Nippon Chemiphar, Sawai and Towa.

Published By: MP Advisors
Product Code: Access China Management Consulting Ltd14


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • Global Tretinoin Market by Manufacturers, Regions, Type and Application, Forecast to 2022

    Tretinoin is the pharmaceutical form of retinoic acid. One of several retinoids, it is the carboxylic acid form of vitamin A and is also known as all-trans retinoic acid (ATRA). It is a first generation topical retinoid commonly used topically to tre...

  • Global Pharmaceutical Logistics Market by Manufacturers, Regions, Type and Application, Forecast to 2022

    Pharmaceutical Logistics is the logistics of pharmaceuticals, medical and surgical supplies, medical devices and equipment, and other products needed to support doctors, nurses, and other health and dental care providers. Because itÂ’s final customer...

  • China Vegetarian Softgel Capsules Market Research Report 2017

    Notes: Sales, means the sales volume of Vegetarian Softgel Capsules Revenue, means the sales value of Vegetarian Softgel Capsules This report studies Vegetarian Softgel Capsules in China market, focuses on the top players in China market, with c...

  • China Vegetable Capsules Market Research Report 2017

    Notes: Sales, means the sales volume of Vegetable Capsules Revenue, means the sales value of Vegetable Capsules This report studies Vegetable Capsules in China market, focuses on the top players in China market, with capacity, production, price,...

  • Europe Cefazolin Sodium Market Report 2017

    Notes: Sales, means the sales volume of Cefazolin Sodium Revenue, means the sales value of Cefazolin Sodium This report studies sales (consumption) of Cefazolin Sodium in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and...

  • Europe Artemisinin Market Report 2017

    Notes: Sales, means the sales volume of Artemisinin Revenue, means the sales value of Artemisinin This report studies sales (consumption) of Artemisinin in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focus...

  • Europe Animal Gelatin Capsules Market Report 2017

    Notes: Sales, means the sales volume of Animal Gelatin Capsules Revenue, means the sales value of Animal Gelatin Capsules This report studies sales (consumption) of Animal Gelatin Capsules in Europe market, especially in Germany, France, UK, Rus...

  • Europe Animal Free Soft Gelatin Capsules Market Report 2017

    Notes: Sales, means the sales volume of Animal Free Soft Gelatin Capsules Revenue, means the sales value of Animal Free Soft Gelatin Capsules This report studies sales (consumption) of Animal Free Soft Gelatin Capsules in Europe market, especial...

  • United States Cefazolin Sodium Market Report 2017

    Notes: Sales, means the sales volume of Cefazolin Sodium Revenue, means the sales value of Cefazolin Sodium This report studies sales (consumption) of Cefazolin Sodium in United States market, focuses on the top players, with sales, price, reven...

  • United States Artemisinin Market Report 2017

    Notes: Sales, means the sales volume of Artemisinin Revenue, means the sales value of Artemisinin This report studies sales (consumption) of Artemisinin in United States market, focuses on the top players, with sales, price, revenue and market s...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: